GlassScriptPhysician profile
Demareo Webb
NPI 1588003479
$1,030.64
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $65.82 · 2021: $238 · 2022: $370 · 2023: $118 · 2024: $17.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $135.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $217.48 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $126.73 | 2021-2022 | |
| La Jolla Pharmaceutical Company | $126.00 | 2019-2023 | Xerava |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $114.01 | 2019-2023 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.01 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $65.93 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $51.78 | 2020-2022 | |
| Abbvie INC. | $49.76 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $32.77 | 2019-2022 | |
| Portola Pharmaceuticals, LLC | $27.78 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $24.43 | 2020 | |
| Chiesi USA, INC. | $21.74 | 2022 | |
| Boston Scientific Corporation | $20.00 | 2023 | Watchman Flx |
| Novo Nordisk INC | $19.65 | 2022 | |
| Mylan Specialty L.P. | $17.90 | 2023 | Yupelri |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $16.55 | 2019 | |
| Pfizer INC. | $16.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Demareo Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.